These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 24218766)

  • 1. [Potential and perspective of genetic testing in Renaissance of laboratory medicine].
    Nobori T
    Rinsho Byori; 2013 Aug; 61(8):693-9. PubMed ID: 24218766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pharmacogenomics].
    Nakatani K; Nobori T
    Rinsho Byori; 2013 Nov; 61(11):1018-25. PubMed ID: 24450107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Personalized oncology: recent advances and future challenges.
    Kalia M
    Metabolism; 2013 Jan; 62 Suppl 1():S11-4. PubMed ID: 22999010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pharmacogenomics: hype or hope?].
    Schwab M; Schaeffeler E; Zanger UM; Brauch H; Kroemer HK
    Dtsch Med Wochenschr; 2011 Mar; 136(10):461-7. PubMed ID: 21365522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Company profile: Sequenom, Inc.
    Cantor CR
    Pharmacogenomics; 2012 Apr; 13(5):529-31. PubMed ID: 22462745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Without an adequate ethical infrastructure, the road to personalized medicine will be rocky at best.
    Caplan AL
    Clin Pharmacol Ther; 2012 Oct; 92(4):411-2. PubMed ID: 22992666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of genomics on the path to personalized medicine.
    Tremblay J; Hamet P
    Metabolism; 2013 Jan; 62 Suppl 1():S2-5. PubMed ID: 23021037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Challenge in genome-wide association study for establishment of personalized medicine: focusing on the pharmacogenomics of warfarin and carbamazepine].
    Mushiroda T
    Rinsho Byori; 2013 May; 61(5):422-7. PubMed ID: 23947182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Introductory remarks by chairpersons].
    Kumagai S; Nobori T
    Rinsho Byori; 2013 May; 61(5):419-20. PubMed ID: 23947181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Personalized therapy].
    Hallek M; Wolf J
    Internist (Berl); 2013 Feb; 54(2):145-6. PubMed ID: 23371256
    [No Abstract]   [Full Text] [Related]  

  • 11. Theranostics in primary care: pharmacogenomics tests and beyond.
    Bartlett G; Antoun J; Zgheib NK
    Expert Rev Mol Diagn; 2012 Nov; 12(8):841-55. PubMed ID: 23249202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Personalized medicine 2011].
    Blum HE
    Dtsch Med Wochenschr; 2011 Mar; 136(10):459-60. PubMed ID: 21365521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Personalized medicine in pediatric cardiology: do little changes make a big difference?
    Manickaraj AK; Mital S
    Curr Opin Pediatr; 2012 Oct; 24(5):584-91. PubMed ID: 22890065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Personal genomics: are we debating the right Issues?].
    Vayena E; Mauch F
    Praxis (Bern 1994); 2012 Jul; 101(15):961-4. PubMed ID: 22811328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How novel molecular diagnostic technologies and biomarkers are revolutionizing genetic testing and patient care.
    Baudhuin LM; Donato LJ; Uphoff TS
    Expert Rev Mol Diagn; 2012 Jan; 12(1):25-37. PubMed ID: 22133117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experts foresee huge growth in genetic medicine.
    Watts G
    BMJ; 2011 Oct; 343():d6344. PubMed ID: 21968128
    [No Abstract]   [Full Text] [Related]  

  • 17. The current status and future potential of personalized diagnostics: Streamlining a customized process.
    Richmond TD
    Biotechnol Annu Rev; 2008; 14():411-22. PubMed ID: 18606372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Making personalized cancer medicine a reality: challenges and opportunities in the development of biomarkers and companion diagnostics.
    Parkinson DR; Johnson BE; Sledge GW
    Clin Cancer Res; 2012 Feb; 18(3):619-24. PubMed ID: 22298894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospects of personalized medicine in cardiovascular diseases.
    Lenfant C
    Metabolism; 2013 Jan; 62 Suppl 1():S6-10. PubMed ID: 22999711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Possibilities and limitations of stratified medicine based on biomarkers and targeted therapies in oncology].
    Ludwig WD
    Z Evid Fortbild Qual Gesundhwes; 2012; 106(1):11-22. PubMed ID: 22325103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.